This reflects 31% growth over the same period last year and marks our thirtieth consecutive quarter of sequential revenue growth. Given these trends and momentum we build, exiting the quarter, we ...
TG Therapeutics, Inc. (NASDAQ: TGTX) Q3 2025 Earnings Call Transcript November 3, 2025 TG Therapeutics, Inc. beats earnings ...